Results 41 to 50 of about 269,235 (359)

Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study

British medical journal, 2017
Objective To examine clinical effectiveness and safety of apixaban 2.5 mg, dabigatran 110 mg, and rivaroxaban 15 mg compared with warfarin among patients with atrial fibrillation who had not previously taken an oral anticoagulant.
P. Nielsen, F. Skjøth, M. Søgaard, J. N. Kjældgaard, G. Lip, T. Larsen   +5 more
semanticscholar   +1 more source

Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Meta-analysis.

Gastroenterology, 2017
BACKGROUND & AIMS Liver cirrhosis is complicated by bleeding from portal hypertension but also by portal vein thrombosis (PVT). PVT occurs in approximately 20% to 50% of patients with cirrhosis, and is a warning sign for poor outcome.
L. Loffredo, D. Pastori, A. Farcomeni, F. Violi   +3 more
semanticscholar   +1 more source

Dabigatran Kullanımına Sekonder Nadir Görülen Ciddi Koagülopati

Hitit Medical Journal, 2022
Dabigatran atriyal fibrilasyon (AF) varlığında oluşabilecek inmelerin önlenmesinde kullanılan oral direkt trombin inhibitörüdür. Vitamin K antagonistleri ve varfarin kullanımına kıyasla kanama yan etkilerinin daha az görülmesi ve laboratuar takibi ...
Ecem Sevim, Damla Ortaboz, Sema Uçak Basat, Ridvan Sivritepe   +3 more
doaj   +1 more source

Association of Oral Anticoagulants and Proton Pump Inhibitor Cotherapy With Hospitalization for Upper Gastrointestinal Tract Bleeding

Journal of the American Medical Association (JAMA), 2018
Importance Anticoagulant choice and proton pump inhibitor (PPI) cotherapy could affect the risk of upper gastrointestinal tract bleeding, a frequent and potentially serious complication of oral anticoagulant treatment. Objectives To compare the incidence
W. Ray, Cecilia P. Chung, Cecilia P. Chung, K. Murray, Walter E. Smalley, Walter E. Smalley, J. Daugherty, W. Dupont, C. Stein   +8 more
semanticscholar   +1 more source

Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation.

Blood Advances, 2018
Randomized clinical trials comparing direct oral anticoagulants (DOACs) to warfarin in cancer patients have not been performed. We evaluated the effectiveness and associated risk of DOACs vs warfarin, as well as comparisons of DOACs, in a large ...
Surbhi Shah, F. Norby, Y. Datta, P. Lutsey, R. Maclehose, L. Chen, Á. Alonso   +6 more
semanticscholar   +1 more source

Management of Antithrombotic Agents in Oral Surgery Maria Martinez and Dimitrios A. Tsakiris *

Dentistry Journal, 2015
Systemic anticoagulation with intravenous or oral anticoagulants and antiplatelet agents is an efficient treatment against thromboembolic or cardiovascular disease.
Maria Martinez, Dimitrios A. Tsakiris
doaj   +1 more source

Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation

Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2016
In comparison to warfarin, non–vitamin K antagonist oral anticoagulants (NOACs) have the advantages of ease of dosing, fewer drug interactions, and lack of need for ongoing monitoring.
Xiaoxi Yao, Neena S. Abraham, G. Caleb Alexander, W. Crown, V. Montori, L. Sangaralingham, Bernard J. Gersh, Nilay D. Shah, Peter A Noseworthy   +8 more
semanticscholar   +1 more source

Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study

British medical journal, 2016
Objective To study the effectiveness and safety of the non-vitamin K antagonist oral anticoagulants (novel oral anticoagulants, NOACs) dabigatran, rivaroxaban, and apixaban compared with warfarin in anticoagulant naïve patients with atrial fibrillation ...
T. Larsen, F. Skjøth, P. Nielsen, J. N. Kjældgaard, G. Lip   +4 more
semanticscholar   +1 more source

Direct oral anticoagulants versus vitamin K antagonists after recent ischemic stroke in patients with atrial fibrillation

Annals of Neurology, 2019
We compared outcomes after treatment with direct oral anticoagulants (DOACs) and vitamin K antagonists (VKAs) in patients with atrial fibrillation (AF) and a recent cerebral ischemia.
D. Seiffge, M. Paciaroni, D. Wilson, M. Koga, Kosmas Macha, M. Cappellari, S. Schaedelin, C. Shakeshaft, Masahito Takagi, G. Tsivgoulis, B. Bonetti, B. Kallmünzer, S. Arihiro, A. Alberti, A. Polymeris, G. Ambler, S. Yoshimura, M. Venti, L. Bonati, K. Muir, H. Yamagami, S. Thilemann, R. Altavilla, N. Peters, M. Inoue, T. Bobinger, G. Agnelli, Martin M. Brown, Shoichiro Sato, Monica Acciarresi, H. Jager, P. Bovi, S. Schwab, P. Lyrer, V. Caso, K. Toyoda, D. Werring, S. Engelter, G. M. De Marchis   +38 more
semanticscholar   +1 more source

Clinical impact of the perioperative management of oral anticoagulants in bleeding after colonic endoscopic mucosal resection

BMC Gastroenterology, 2019
Background Heparin bridging therapy (HBT) is indeed related to a high frequency of bleeding after endoscopic mucosal resection (EMR). In this study, our aim was to investigate clinical impact of management of oral anticoagulants without HBT in bleeding ...
Shoko Ono, Marin Ishikawa, Kana Matsuda, Momoko Tsuda, Keiko Yamamoto, Yuichi Shimizu, Naoya Sakamoto   +6 more
doaj   +1 more source